http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2277941-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M21-00 |
| filingDate | 2004-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057965ff3ea1d5aadcee26f8288ee5e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29b2889189aabff63b7cb97b014dbbf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25078e756d91942c623cfac1aed0b0a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2740f6753b53e1edf38c4d05ee6317b4 |
| publicationDate | 2006-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2277941-C2 |
| titleOfInvention | Method for treating alcoholism |
| abstract | FIELD: medicine, psychotherapy. n SUBSTANCE: one should carry out rational psychotherapy to establish a confidential contact with a patient, to analyze purposes of therapy and perform suggestion for sober life due to a motivated suggestion. Then one should conduct neuro-linguistic programming - reframing due to applying "a part of subconsciousness" statement to choose new ways of behavior instead of alcoholic addiction and become responsible for carrying out these ways in future, followed by fixing this state with the help of kinesthetic conditioned stimulus. In the course of the second seance one should carry out neuro-linguistic programming - reframing at developing indifferent and stable attitude to alcohol. During the third seance it is necessary to conduct behavioral psychotherapy by applying the technique of neuro-linguistic programming "The shift of anchors" to form disgust to alcohol under any life conditions. After the third seance one should prescribe antidepressant preparation profluzak, 20 mg once daily, for 20 d. The innovation enables to develop new stereotype of alcohol-free behavior at increased quality of prolonged terms of remission due to treating depressive disorder in due time. n EFFECT: higher efficiency of therapy. n 1 cl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2629529-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2629530-C1 |
| priorityDate | 2004-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393347 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410 |
Total number of triples: 18.